News for 'Drug Administration'

Biden, wife to receive Pfizer COVID-19 vaccine on Monday

Biden, wife to receive Pfizer COVID-19 vaccine on Monday

Rediff.com19 Dec 2020

Biden previously told Jake Tapper of CNN that he would be "happy to" take the COVID-19 vaccine once US infectious disease expert Anthony Fauci said it was safe and he would get the injection in a public setting to prove it.

Chemists call for nationwide strike on Oct 14

Chemists call for nationwide strike on Oct 14

Rediff.com1 Oct 2015

The introduction of e-pharmacy, to protect the interest of a handful of players, would hamper the interest of 800,000 chemists and 80 lakh workers and their families

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Rediff.com13 Dec 2019

Portfolios were distributed 2 weeks after the MVA govt was sworn-in. Shiv Sena's Eknath Shinde will be home minister while NCP's Jayant Patil will be finance minister.

Sayre Therapeutics: In the business of cancer

Sayre Therapeutics: In the business of cancer

Rediff.com21 Sep 2017

Sayre Therapeutics aims for a spot among top 5 players in oncology.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

US authorizes Pfizer's COVID vaccine for emergency use

US authorizes Pfizer's COVID vaccine for emergency use

Rediff.com12 Dec 2020

According to The New York Times, this move means that many highly vulnerable people will begin receiving the vaccine within days. It further called the authorisation by the FDA as a 'historic turning point' as the US death toll from the Wuhan-originated virus nears 300,000.

Serum to double Covid vaccine output in 2022

Serum to double Covid vaccine output in 2022

Rediff.com13 Jul 2021

SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Rediff.com12 Sep 2014

Sun Pharma stated the company wanted shareholders' approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants, up to an amount of Rs 12,000 crore ($2 billion), to qualified institutional buyers pursuant to a QIP."

3 Indian cos to make NASA's Covid ventilators

3 Indian cos to make NASA's Covid ventilators

Rediff.com30 May 2020

The three Indian companies are Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd, the space organisation said in a statement on Friday.

How India's pharma growth story fizzled out

How India's pharma growth story fizzled out

Rediff.com5 Jul 2017

Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.

Pune: Covid patients' kin stage protest over Remdesivir shortage

Pune: Covid patients' kin stage protest over Remdesivir shortage

Rediff.com15 Apr 2021

Earlier, the district administration had issued an order that hospitals should not be asking patient's relatives to arrange the Remdesivir injection from outside, and instead, they should themselves procure it from chemists based on their requirement and use it for treatment.

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

Rediff.com17 Mar 2016

It is one of 42 drug-making factories in India that the FDA has banned in recent years

Rosier year-end seen for Indian pharma, thanks to faster US approvals

Rosier year-end seen for Indian pharma, thanks to faster US approvals

Rediff.com12 Oct 2015

Rosier year-end seen for Indian pharma thanks to faster US approvals.

USFDA raises concerns about Ranbaxy's Toansa plant

USFDA raises concerns about Ranbaxy's Toansa plant

Rediff.com13 Jan 2014

All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.

Regulator finds procedural lapses at Wockhardt's US facility

Regulator finds procedural lapses at Wockhardt's US facility

Rediff.com3 Jun 2014

The FDA had imposed a ban on the company's Waluj plant in May.

2 prominent Indian-Americans among Biden's core advisers

2 prominent Indian-Americans among Biden's core advisers

Rediff.com30 Oct 2020

Biden, 'plotting an ambitious presidency that would begin amid twin health and economic crises, is leaning on veteran advisers with high-level governmental experience rather than outsiders and ideological rivals to help guide him on subjects including the coronavirus pandemic and the country's diminished standing in the world', a report in The New York Times said.

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

What is meldonium? Why did Sharapova use it?

What is meldonium? Why did Sharapova use it?

Rediff.com8 Mar 2016

What we must know about the substance the Russian tennis ace was taking before it was banned this year.

Covid vaccine boosters not appropriate at this stage: Lancet study

Covid vaccine boosters not appropriate at this stage: Lancet study

Rediff.com13 Sep 2021

The results reported from the observational studies, on average, show that vaccination had 95 per cent efficacy against severe disease both from the Delta variant and from the Alpha variant, and over 80 per cent efficacy at protecting against any infection from these variants.

'Centre can't abdicate its responsibility'

'Centre can't abdicate its responsibility'

Rediff.com24 Apr 2023

'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'

Indian pharma exports report double-digit growth after 3 yrs

Indian pharma exports report double-digit growth after 3 yrs

Rediff.com3 May 2019

The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

Maharashtra government bans Maggi

Maharashtra government bans Maggi

Rediff.com6 Jun 2015

Maharashtra government on Friday decided to put a ban on Maggi noodles after some samples were found to contain lead above the permissible limit.

In talks with India over 'expedited approval' of Covid vaccine: Pfizer

In talks with India over 'expedited approval' of Covid vaccine: Pfizer

Rediff.com3 May 2021

Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Ranbaxy Q4 net loss at Rs 73.6 crore

Ranbaxy Q4 net loss at Rs 73.6 crore

Rediff.com9 May 2014

It had posted net profit of Rs 125.75 crore (Rs 1.25 billion) during the January-March quarter of the previous fiscal, 2012-13.

3 sectors to watch for as economic growth picks up

3 sectors to watch for as economic growth picks up

Rediff.com12 Jan 2021

Overall, the credit profiles of players will be supported by healthy balance sheets and liquidity. Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

US registers record day toll of 2,129; total at 25,000

US registers record day toll of 2,129; total at 25,000

Rediff.com15 Apr 2020

A record number of 2,129 of Americans died in one single day, the previous highest being 2,074 on April 10. New York has become the epicentre of the country's outbreak with 2,03,020 confirmed cases and 10,842 deaths so far.

What exactly is wrong with India's pharma companies?

What exactly is wrong with India's pharma companies?

Rediff.com12 Sep 2017

Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation

'Everybody's going to get infected'

'Everybody's going to get infected'

Rediff.com27 Dec 2021

'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'

US VP Mike Pence receives COVID-19 vaccine on camera

US VP Mike Pence receives COVID-19 vaccine on camera

Rediff.com18 Dec 2020

"Confidence in the vaccine is what brings us here this morning," the US vice-president said in remarks following his vaccination. "I didn't feel a thing. Well done."

Aaftab Poonawala to undergo narco test on December 1

Aaftab Poonawala to undergo narco test on December 1

Rediff.com29 Nov 2022

On Monday, Poonawala had come under an attack by some weapon-wielding men at the FSL when he was in a police van.

China rolls out first one-jab COVID-19 vaccine: Report

China rolls out first one-jab COVID-19 vaccine: Report

Rediff.com28 Feb 2021

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.

Pursuing foreign companies since mid-2020 for possible vaccine imports: Govt

Pursuing foreign companies since mid-2020 for possible vaccine imports: Govt

Rediff.com27 May 2021

Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers.

PIL against Ranbaxy: SC questions advocate

PIL against Ranbaxy: SC questions advocate

Rediff.com10 Jun 2013

The Supreme Court on Monday posed some tough questions to a lawyer, asking him to substantiate his "unfounded allegations" in a PIL that Indian pharma major Ranbaxy Laboratories Ltd was allegedly manufacturing and selling adulterated medicines.

Nasal Covid Vaccine Available In Jan

Nasal Covid Vaccine Available In Jan

Rediff.com28 Dec 2022

The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine.

Pfizer, Moderna testing vaccines against UK Covid strain

Pfizer, Moderna testing vaccines against UK Covid strain

Rediff.com22 Dec 2020

The novel coronavirus has mutated before, and both companies say they've found that their vaccines worked against other variations of the virus.

Manipur: Not A Time To Burn Bridges

Manipur: Not A Time To Burn Bridges

Rediff.com7 Jun 2023

The present happenings in Manipur are the wages of continued neglect, and not so benign at that, of a vital region and its people. Had we lavished on the North East even a fraction of the care and resources we do on Kashmir, things would not have come to this pass, asserts Shreekant Sambrani.